Collectively, these data supported that MAPK6 and mTORC2 independently and coordinately promote AKT phosphorylation/activation and that MAPK6 emerges as a key regulator for cancer cells’ response to mTOR kinase blockade. This evidence concerns the gene AKT1 and cancer.